Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

AVITA Medical, Inc. RCEL

Set alert

Price alert · RCEL

All alert types
16.58 USD +1.17 +7.58%

As of Nov 3, 11:09 AM ET

Bid
16.54 × 1
Ask
16.68 × 2
15.05 Day range 16.60
3.22 52-week range 16.90
YTD
+380.52%
1 year
+338.57%
Open
15.24
Prev close
15.41
Mkt cap
513.23M
Vol
120.99K
Avg vol
495.94K
EPS
-1.43
P/E
0.00
Div yield
0.00%
More statistics
Low
15.05
High
16.60
Forward P/E
-14.33
Beta
1.54
Short ratio
10.24
Inst. own
23.45%
Dividend
0.00
Ex-div date
50-d avg
11.87
200-d avg
10.61
1y target
16.81

6M chart

Chart tools
Interval
1m5m15m30m

Signals (41)
NameDateAgo
MACD: Buy SignalOct 21, 20261 week ago
RSI: OverboughtOct 21, 20261 week ago
MACD: Sell SignalOct 14, 20262 weeks ago
MACD: Buy SignalOct 2, 20261 month ago
RSI: OverboughtOct 2, 20261 month ago
RSI: OverboughtSep 17, 20261 month ago
MACD: Sell SignalSep 1, 20262 months ago
MACD: Buy SignalAug 7, 20262 months ago
RSI: OverboughtAug 7, 20262 months ago
MACD: Sell SignalJul 27, 20263 months ago
MACD: Buy SignalJul 16, 20263 months ago
SMA: BullishJul 15, 20263 months ago
SMA: BullishJul 15, 20263 months ago
MACD: Sell SignalJul 13, 20263 months ago
SMA: BearishJul 10, 20263 months ago
SMA: BearishJul 10, 20263 months ago
RSI: OverboughtJul 2, 20264 months ago
SMA: BullishJul 1, 20264 months ago
SMA: BullishJul 1, 20264 months ago
MACD: Buy SignalJun 29, 20264 months ago

Newest 20 of 41.

Analyst view

Consensus: buy

Buy
Price target (mean) 16.81 +1.4% upside
Target (low)
11.38
Target (mean)
16.81
Target (high)
20.95
Ratings (0m) 5 3 buy · 2 hold · 0 sell
  • Strong buy0
  • Buy3
  • Hold2
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 5
  • 1 month ago 5
  • 2 months ago 6

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

RCEL analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.56534-0.703 – -0.304-0.42801-32.1%35.67M+64.4%6
Next quarter-0.70833-1.26 – -0.272-1.11+35.9%34.14M+103.1%3
Current year-3.28-3.82 – -2.23-2.14-53.3%106.10M+38.4%7
Next year-1.28-2.72 – -0.09097-3.28+61.1%161.14M+51.9%7

Upgrades and downgrades

The latest rating changes

RCEL analyst upgrades and downgrades
DateFirmActionFromTo
Nov 8, 2024Piper SandlerReiteratedNeutralNeutral
Aug 9, 2024Cantor FitzgeraldReiteratedOverweightOverweight
May 14, 2024Piper SandlerDowngradeOverweightNeutral
May 14, 2024Cantor FitzgeraldMaintainedOverweightOverweight
Apr 11, 2024BTIGDowngradeBuyNeutral
Feb 23, 2024Piper SandlerReiteratedOverweightOverweight
Feb 23, 2024Cantor FitzgeraldMaintainedOverweightOverweight
Jan 19, 2024Cantor FitzgeraldMaintainedOverweightOverweight
Nov 21, 2023Cantor FitzgeraldReiteratedOverweightOverweight
Nov 10, 2023Piper SandlerMaintainedOverweightOverweight
Oct 19, 2023Cantor FitzgeraldReiteratedOverweightOverweight
Sep 26, 2023Cantor FitzgeraldReiteratedOverweightOverweight
Aug 22, 2023Cantor FitzgeraldReiteratedOverweightOverweight
Aug 11, 2023Piper SandlerMaintainedOverweightOverweight
Jul 28, 2023B of A SecuritiesMaintainedBuyBuy
Jul 13, 2023Lake StreetMaintainedBuyBuy
Jun 27, 2023Cantor FitzgeraldInitiated—Overweight
Jun 26, 2023Lake StreetMaintainedBuyBuy
Jun 9, 2023Lake StreetMaintainedBuyBuy
May 12, 2023Lake StreetMaintainedBuyBuy
May 12, 2023Piper SandlerMaintainedOverweightOverweight
Apr 17, 2023BTIGMaintained—Buy
Feb 24, 2023Lake StreetMaintainedBuyBuy
Mar 2, 2021Piper SandlerInitiated—Overweight
Aug 27, 2020B of A SecuritiesInitiated—Buy
Jul 9, 2020BTIGMaintained—Buy